SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lianqin Tao, Baoyu Shi, Guochao Shi, Huanying Wan, Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials, The Clinical Respiratory Journal, 2014, 8, 2
  2. 2
    Giorgio Canonica, Linda Cox, Ruby Pawankar, Carlos E Baena-Cagnani, Michael Blaiss, Sergio Bonini, Jean Bousquet, Moises Calderón, Enrico Compalati, Stephen R Durham, Roy van Wijk, Désirée Larenas-Linnemann, Harold Nelson, Giovanni Passalacqua, Oliver Pfaar, Nelson Rosário, Dermot Ryan, Lanny Rosenwasser, Peter Schmid-Grendelmeier, Gianenrico Senna, Erkka Valovirta, Hugo Van Bever, Pakit Vichyanond, Ulrich Wahn, Osman Yusuf, Sublingual immunotherapy: World Allergy Organization position paper 2013 update, World Allergy Organization Journal, 2014, 7, 1, 6

    CrossRef

  3. 3
    Marco Caminati, Annarita Dama, Michele Schiappoli, Gianenrico Senna, Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?, Expert Review of Clinical Immunology, 2013, 9, 10, 937

    CrossRef

  4. 4
    Sandra Y. Lin, Current Concepts and Update for Sublingual Immunotherapy, Current Otorhinolaryngology Reports, 2013, 1, 2, 99

    CrossRef

  5. 5
    Giovanni Passalacqua, Carlos E. Baena-Cagnani, Jean Bousquet, Giorgio Walter Canonica, Thomas B. Casale, Linda Cox, Stephen R. Durham, Desiréé Larenas-Linnemann, Dennis Ledford, Ruby Pawankar, Paul Potter, Nelson Rosario, Dana Wallace, Richard F. Lockey, Grading local side effects of sublingual immunotherapy for respiratory allergy: Speaking the same language, Journal of Allergy and Clinical Immunology, 2013, 132, 1, 93

    CrossRef

  6. 6
    Juliane Köberlein, Ralph Mösges, Oralair®: a causal treatment for grass pollen-induced allergic rhinoconjunctivitis, Immunotherapy, 2013, 5, 1, 13

    CrossRef

  7. 7
    Gianenrico Senna, Marco Caminati, Giorgio Walter Canonica, Safety and tolerability of sublingual immunotherapy in clinical trials and real life, Current Opinion in Allergy and Clinical Immunology, 2013, 13, 6, 656

    CrossRef

  8. 8
    V. Vovolis, L. Kalogiros, D. Mitsias, E. Sifnaios, Severe repeated anaphylactic reactions to sublingual immunotherapy, Allergologia et Immunopathologia, 2013, 41, 4, 279

    CrossRef

  9. 9
    Adrienne M. Laury, Rodney J. Schlosser, Sarah K. Wise, Sublingual immunotherapy and quality of life, Current Opinion in Otolaryngology & Head and Neck Surgery, 2013, 21, 3, 252

    CrossRef

  10. 10
    Giovanni Passalacqua, Valentina Garelli, Francesca Sclifò, Giorgio Walter Canonica, Sublingual immunotherapy for allergic rhinitis and conjunctivitis, Immunotherapy, 2013, 5, 3, 257

    CrossRef

  11. 11
    Antonio Cappella, Stephen R. Durham, Allergen immunotherapy for allergic respiratory diseases, Human vaccines & immunotherapeutics, 2012, 8, 10, 1499

    CrossRef

  12. 12
    George F. Kroker, Vijay K. Sabnis, Mary S. Morris, James C. Thompson, Comment on “Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review”, Journal of Allergy, 2012, 2012, 1

    CrossRef

  13. 13
    M.A. Calderón, P. Rodriguez del Rio, P. Demoly, Sublingual allergen immunotherapy in children: An evidence-based overview, Revue Française d'Allergologie, 2012, 52, 1, 20

    CrossRef

  14. 14
    M. A. Calderón, F. E. R. Simons, H.-J. Malling, R. F. Lockey, P. Moingeon, P. Demoly, Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile, Allergy, 2012, 67, 3
  15. 15
    Takashi Fujimura, Yoshitaka Okamoto, Masaru Taniguchi, Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review, Journal of Allergy, 2012, 2012, 1